UC
LKFT

Unterberg Capital’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Unterberg Capital’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-12,000
Closed -$1.11M – 20
2018
Q2 		$1.11M Hold
12,000
– – 1.31% 19
2018
Q1 		$1.2M Hold
12,000
– – 1.4% 24
2017
Q4 		$1.13M Buy
+12,000
New +$1.14M 1.38% 23

Other funds holding LKFT

Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Unterberg Capital's LKFT Position: Q3 2018 in Review

Unterberg Capital sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2018, closing a stake of 12,000 shares — an estimated $1.11M sold.

Unterberg Capital first reported a position in LKFT in Q4 2017 and held it in 3 quarters. The position peaked at $1.2M in Q1 2018. 92 funds tracked by Wall St. Rank hold LKFT as of Q3 2018.

  • Unterberg Capital reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2018 after selling out during the quarter.
  • Unterberg Capital sold 12,000 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2018, an estimated $1.11M.
  • Unterberg Capital first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2017 and held it in 3 quarters.
  • Unterberg Capital's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.2M in Q1 2018.
  • 92 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2018.

Based on Unterberg Capital's 13F filing for Q3 2018, filed 24 Oct 2018.